Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study)

INTRODUCTION: Although there are studies about sepsis treatment in different age groups, data on immunoglobulin-M (IgM)-enriched intravenous immunoglobulin use in pediatric intensive care units (PICUs) are limited. The aim of this study was to evaluate the clinical features and prognoses of children...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullayev, Emin, Kilic, Omer, Bozan, Gurkan, Kiral, Eylem, Iseri Nepesov, Merve, Dinleyici, Ener Cagri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482735/
https://www.ncbi.nlm.nih.gov/pubmed/32040371
http://dx.doi.org/10.1080/21645515.2019.1711298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482735/
https://www.ncbi.nlm.nih.gov/pubmed/32040371
http://dx.doi.org/10.1080/21645515.2019.1711298

Ejemplares similares